Instaflex BR Tablet is a combination pharmaceutical formulation containing Bromelain (180 mg), Trypsin (96 mg), and Rutoside (200 mg), designed to provide anti-inflammatory, analgesic, and vascular protective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, exhibits potent anti-inflammatory and fibrinolytic properties, aiding in the reduction of edema and pain associated with musculoskeletal disorders, postoperative swelling, and trauma. Trypsin, another proteolytic enzyme, enhances the anti-inflammatory action by facilitating the breakdown of inflammatory mediators and promoting tissue repair. Rutoside, a bioflavonoid, contributes to vascular health by strengthening capillary walls, reducing capillary permeability, and exhibiting antioxidant effects, thereby mitigating oxidative stress and improving microcirculation. The synergistic action of these components makes Instaflex BR Tablet effective in managing conditions such as arthritis, sports injuries, and other inflammatory disorders. It is typically prescribed as an adjunct to conventional therapy to accelerate recovery and improve patient comfort. The tablet should be used under medical supervision, considering contraindications such as hypersensitivity to any component, bleeding disorders, or concurrent anticoagulant therapy. Adherence to recommended dosage and monitoring for adverse effects is essential to ensure therapeutic efficacy and safety.